| Literature DB >> 34970524 |
Mohsen Abbasi-Kangevari1, Shahnam Arshi1, Hossein Hassanian-Moghaddam1, Ali-Asghar Kolahi1.
Abstract
Background: The rapidly growing imbalance between supply and demand for ventilators during the COVID-19 pandemic has highlighted the principles for fair allocation of scarce resources. Failing to address public views and concerns on the subject could fuel distrust. The objective of this study was to determine the priorities of the Iranian public toward the fair allocation of ventilators during the COVID-19 pandemic.Entities:
Keywords: SARS-CoV-2; coronavirus infections; ethics; health care rationing; health policy; mechanical ventilators; resource allocation
Mesh:
Year: 2021 PMID: 34970524 PMCID: PMC8712311 DOI: 10.3389/fpubh.2021.753048
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Socio-demographic characteristics of participants.
|
| |
|---|---|
|
| |
| Female | 1,122 (54.9) |
| Male | 921 (45.1) |
|
| |
| Never married | 823 (40.2) |
| Engaged | 45 (2.2) |
| Married | 1,127 (55.2) |
| Divorced | 40 (2.0) |
| Widowed | 8 (0.4) |
|
| |
| Fars | 1,145 (56.1) |
| Turk/Azari | 449 (22.0) |
| Kurd | 129 (6.3) |
| Lor | 88 (4.3) |
| Other | 232 (11.3) |
|
| |
| High school diploma | 475 (23.2) |
| Associate degree | 121 (5.9) |
| Bachelor | 861 (42.1) |
| Master | 375 (18.4) |
| Ph.D. and higher | 197 (9.8) |
| Other | 14 (5.6) |
|
| |
| Yes | 274 (13.4) |
| No | 1,769 (86.6) |
Participants' responses on prioritizing ventilator allocation among sub-groups of patients with COVID-19 who need mechanical ventilation.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Female gender | 12 (0.6) | 8 (0.4) | 1,515 (74.2) | 269 (13.2) | 239 (11.6) |
|
| |||||
| <40 | 14 (0.7) | 99 (4.8) | 870 (42.6) | 538 (26.3) | 522 (25.6) |
| 41–60 | 15 (0.8) | 74 (3.6) | 936 (45.8) | 756 (37.0) | 262 (12.8) |
| 61–80 | 123 (6.0) | 483 (23.6) | 801 (39.2) | 287 (14.1) | 349 (17.1) |
| >80 | 585 (28.6) | 463 (22.7) | 534 (26.1) | 164 (8.0) | 297 (14.6) |
| Iranian nationality | 26 (1.3) | 30 (1.5) | 1,300 (63.6) | 213 (10.4) | 474 (23.2) |
| Muslim religion | 61 (3.0) | 13 (0.6) | 1,792 (87.7) | 64 (3.1) | 113 (5.6) |
|
| |||||
| of COVID-19 patients | 10 (0.5) | 6 (0.3) | 509 (24.9) | 578 (28.3) | 940 (46.0) |
| not for COVID-19 patients | 26 (1.3) | 30 (1.5) | 1,388 (67.9) | 427 (20.9) | 172 (8.4) |
|
| |||||
| of COVID-19 patients | 9 (0.4) | 8 (0.4) | 490 (24.0) | 651 (31.9) | 885 (43.3) |
| not for COVID-19 patients | 25 (1.2) | 26 (1.3) | 1,404 (68.7) | 425 (20.8) | 163 (8.0) |
| Other healthcare professionals | 27 (1.3) | 23 (1.1) | 1,535 (75.1) | 324 (15.9) | 134 (6.6) |
| High socioeconomic status | 142 (7.0) | 86 (4.2) | 1,743 (85.3) | 43 (2.1) | 29 (1.4) |
| High-profile governmental position | 637 (31.2) | 124 (6.1) | 1,182 (57.9) | 62 (3.0) | 38 (1.8) |
| Nobel research position | Zero | Zero | 939 (42.6) | 631 (28.7) | 631 (28.7) |
| High-profile occupation | 77 (3.8) | 39 (1.9) | 1,560 (76.3) | 274 (13.4) | 93 (4.6) |
| Celebrities | 87 (4.3) | 46 (2.3) | 1,735 (84.9) | 123 (6.0) | 52 (2.5) |
| Unemployment | 24 (1.2) | 24 (1.2) | 1,799 (88.1) | 97 (4.7) | 99 (4.8) |
| Pregnancy | 9 (0.4) | 3 (0.1) | 198 (9.7) | 651 (31.9) | 1182 (57.9) |
| Having <2 years old child | 7 (0.3) | Zero | 274 (13.4) | 655 (32.1) | 1107 (54.2) |
| Smoking | 114 (5.6) | 212 (10.4) | 1,517 (74.3) | 116 (5.7) | 84 (4.0) |
| Drug abuse | 332 (16.3) | 390 (19.0) | 1,209 (59.2) | 73 (3.6) | 39 (1.9) |
| Having underlying disease | 15 (0.7) | 54 (2.6) | 564 (27.6) | 815 (39.9) | 595 (29.2) |
| Immunocompromise | 30 (1.5) | 70 (3.4) | 509 (24.9) | 753 (36.9) | 681 (33.3) |
| Malignancy | 78 (3.8) | 172 (8.4) | 520 (25.5) | 639 (31.3) | 634 (31.0) |
| End-stage status | 428 (20.9) | 510 (25.0) | 802 (39.3) | 137 (6.7) | 166 (8.1) |
| Obesity | 16 (0.8) | 43 (2.1) | 1,649 (80.7) | 210 (10.3) | 125 (6.1) |
Dispersion measures of participants' responses on prioritizing ventilator allocation among sub-groups of patients with COVID-19 who need mechanical ventilation.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Female gender | Equal | 0.4 (0.7) | 0.3 to 0.4 | 0 (0 to 1) | 1.2 |
|
| |||||
| <40 | Equal | 0.7 (0.9) | 0.7 to 0.8 | 1 (0,2) | Zero |
| 41–60 | Equal | 0.6 (0.8) | 0.5 to 0.6 | 0 (0,1) | 0.1 |
| 61–80 | Equal | 0.1 (1.2) | 0.1 to 0.2 | 0 (−1,1) | 0.2 |
| >80 | Very low | −0.4 (1.4) | (−0.5) to (−0.3) | −1 (−2,0) | 0.5 |
| Iranian nationality | Equal | 0.5 (0.9) | 0.5 to 0.6 | 0 (0,1) | 0.5 |
| Muslim religion | Equal | 0.1 (0.6) | 0.06 to 0.11 | 0 (0,0) | 0.7 |
|
| |||||
| of COVID-19 patients | Very high | 1.2 (0.9) | 1.1 to 1.2 | 1 (0,2) | −0.6 |
| not for COVID-19 patients | Equal | 0.3 (0.7) | 0.3 to 0.4 | 0 (0,1) | 0.6 |
|
| |||||
| of COVID-19 patients | Very high | 1.2 (0.8) | 1.1 to 1.2 | 1 (1,2) | −0.6 |
| not for COVID-19 patients | Equal | 0.3 (0.7) | 0.3 to 0.4 | 0 (0,1) | 0.7 |
| Other healthcare professionals | Equal | 0.3 (0.7) | 0.2 to 0.3 | 0 (0,0) | 0.8 |
| High socioeconomic status | Equal | −0.1 (0.6) | (−0.2) to (−0.1) | 0 (0,0) | −1.2 |
| High-profile governmental position | Equal | −0.6 (1) | (−0.6) to (−0.5) | 0 (−2,0) | −0.2 |
| Nobel research position | Equal | 0.9 (0.8) | 0.8 to 0.9 | 1 (0,2) | 0.3 |
| High-profile occupation | Equal | 0.1 (0.7) | 0.1 to 0.2 | 0 (0,0) | Zero |
| Celebrities | Equal | 0 (0.6) | −0.01 to 0.04 | 0 (0,0) | −0.4 |
| Unemployment | Equal | 0.1 (0.5) | 0.08 to 0.13 | 0 (0,0) | 1.4 |
| Pregnancy | Very high | 1.5 (0.7) | 1.4 to 1.5 | 2 (1,2) | −1.3 |
| Having <2 years old child | Very high | 1.4 (0.7) | 1.3 to 1.4 | 2 (1,2) | −1 |
| Smoking | Equal | −0.1 (0.7) | (−0.1) to 0 | 0 (0,0) | −0.1 |
| Drug abuse | Equal | −0.4 (0.9) | (−0.5) to (−0.4) | 0 (−1,0) | −0.3 |
| Having underlying disease | High | 0.9 (0.9) | 0.9 to 1 | 1 (0,2) | −0.5 |
| Immunocompromise | High | 1 (0.9) | 0.9 to 1 | 1 (0,2) | −0.6 |
| Malignancy | High | 0.8 (1.1) | 0.7 to 0.8 | 1 (0,2) | −0.6 |
| End-stage status | Equal | −0.4 (1.1) | (−0.5) to (−0.4) | 0 (−1,0) | 0.4 |
| Obesity | Equal | 0.2 (0.6) | 0.17 to 0.22 | 0 (0,0) | 1.3 |
The mean priority score assigned to each sub-group of patients with COVID-19 among men and women.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
| ||||
|
|
|
|
| ||
| Female gender | 0.4 (0.7) | 0.4 to 0.4 | 0.3 (0.7) | 0.2 to 0.3 | <0.001 |
|
| |||||
| <40 | 0.8 (0.9) | 0.7 to 0.8 | 0.6 (0.9) | 0.6 to 0.7 | N/S |
| 41–60 | 0.6 (0.8) | 0.6 to 0.7 | 0.5 (0.8) | 0.4 to 0.5 | <0.001 |
| 61–80 | 0.2 (1.1) | 0.1 to 0.2 | 0.1 (1.2) | 0 to 0.2 | N/S |
| >80 | −0.4 (1.3) | (−0.5) to (−0.3) | −0.4 (1.5) | (−0.5) to (−0.3) | N/S |
| Iranian nationality | 0.5 (0.9) | 0.4 to 0.5 | 0.6 (0.9) | 0.5 to 0.7 | <0.001 |
| Muslim religion | 0.1 (0.5) | 0.1 to 0.1 | 0.1 (0.7) | 0 to 0.1 | N/S |
|
| |||||
| of COVID-19 patients | 1.2 (0.8) | 1.1 to 1.2 | 1.2 (0.9) | 1.2 to 1.3 | N/S |
| not for COVID-19 patients | 0.4 (0.7) | 0.3 to 0.4 | 0.3 (0.8) | 0.3 to 0.4 | N/S |
|
| |||||
| of COVID-19 patients | 1.1 (0.8) | 1.1 to 1.2 | 1.2 (0.9) | 1.1 to 1.2 | N/S |
| not for COVID-19 patients | 0.3 (0.7) | 0.3 to 0.4 | 0.3 (0.7) | 0.3 to 0.4 | N/S |
| Other healthcare professionals | 0.3 (0.6) | 0.3 to 0.3 | 0.2 (0.7) | 0.2 to 0.3 | 0.004 |
| High socioeconomic status | −0.1 (0.5) | (−0.1) to (−0.1) | −0.2 (0.7) | (−0.2) to (−0.1) | N/S |
| High-profile governmental position | −0.5 (0.9) | (−0.6) to (−0.5) | −0.7 (1.1) | (−0.7) to (−0.6) | 0.04 |
| Nobel research position | 0.8 (0.8) | 0.8 to 0.9 | 0.9 (0.8) | 0.9 to 1 | <0.001 |
| High-profile occupation | 0.1 (0.6) | 0.1 to 0.2 | 0.1 (0.8) | 0.1 to 0.2 | N/S |
| Celebrities | 0.1 (0.5) | 0 to 0.1 | 0 (0.7) | (−0.1) to 0 | 0.01 |
| Unemployment | 0.1 (0.5) | 0.1 to 0.1 | 0.1 (0.6) | 0.1 to 0.1 | N/S |
| Pregnancy | 1.5 (0.7) | 1.4 to 1.5 | 1.5 (0.7) | 1.4 to 1.5 | N/S |
| Having <2 years old child | 1.4 (0.7) | 1.4 to 1.5 | 1.3 (0.8) | 1.3 to 1.4 | <0.001 |
| Smoking | 0 (0.7) | (−0.1) to 0 | −0.1 (0.8) | (−0.2) to (−0.1) | <0.001 |
| Drug abuse | −0.4 (0.9) | (−0.5) to (−0.4) | −0.5 (0.9) | (−0.5) to (−0.4) | 0.02 |
| Having underlying disease | 1 (0.8) | 1 to 1.1 | 0.8 (0.9) | 0.8 to 0.9 | <0.001 |
| Immunocompromise | 1.1 (0.9) | 1 to 1.1 | 0.8 (1) | 0.8 to 0.9 | <0.001 |
| Malignancy | 0.9 (1) | 0.9 to 1 | 0.6 (1.1) | 0.5 to 0.7 | <0.001 |
| End-stage status | −0.3 (1.1) | (−0.4) to (−0.3) | −0.6 (1.2) | (−0.6) to (−0.5) | <0.001 |
| Obesity | 0.2 (0.6) | 0.2 to 0.3 | 0.1 (0.6) | 0.1 to 0.2 | <0.001 |
Not significant.
The mean priority score assigned to each sub-group of patients with COVID-19 among healthcare workers and non-healthcare workers.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
| ||||
|
|
|
|
| ||
| Female gender | 0.3 (0.6) | 0.2 to 0.4 | 0.4 (0.7) | 0.3 to 0.4 | N/S |
|
| |||||
| <40 | 0.8 (0.9) | 0.7 to 0.9 | 0.7 (0.9) | 0.7 to 0.7 | 0.02 |
| 41–60 | 0.6 (0.8) | 0.6 to 0.7 | 0.6 (0.8) | 0.5 to 0.6 | N/S |
| 61–80 | 0.1 (1) | (−0.1) to 0.2 | 0.1 (1.2) | 0.1 to 0.2 | N/S |
| >80 | −0.6 (1.2) | (−0.7) to (−0.5) | −0.4 (1.4) | (−0.4) to (−0.3) | 0.01 |
| Iranian nationality | 0.5 (0.8) | 0.4 to 0.6 | 0.5 (0.9) | 0.5 to 0.6 | N/S |
| Muslim religion | 0 (0.5) | 0 to 0.1 | 0.1 (0.6) | 0.1 to 0.1 | N/S |
|
| |||||
| of COVID-19 patients | 1.3 (0.8) | 1.2 to 1.4 | 1.2 (0.9) | 1.1 to 1.2 | N/S |
| not for COVID-19 patients | 0.6 (0.8) | 0.6 to 0.7 | 0.3 (0.7) | 0.3 to 0.3 | <0.001 |
|
| |||||
| of COVID-19 patients | 1.2 (0.8) | 1.1 to 1.3 | 1.2 (0.8) | 1.1 to 1.2 | N/S |
| not for COVID-19 patients | 0.6 (0.8) | 0.5 to 0.7 | 0.3 (0.7) | 0.3 to 0.3 | <0.001 |
| Other healthcare professionals | 0.5 (0.7) | 0.4 to 0.6 | 0.2 (0.6) | 0.2 to 0.2 | <0.001 |
| High socioeconomic status | 0 (0.6) | (−0.1) to 0 | −0.1 (0.6) | (−0.2) to (−0.1) | <0.001 |
| High-profile governmental position | −0.5 (1) | (−0.6) to (−0.4) | −0.6 (1) | (−0.7) to (−0.6) | N/S |
| Nobel research position | 1.1 (0.9) | 1 to 1.2 | 0.8 (0.8) | 0.8 to 0.9 | <0.001 |
| High-profile occupation | 0.3 (0.7) | 0.2 to 0.3 | 0.1 (0.7) | 0.1 to 0.2 | <0.001 |
| Celebrities | 0.2 (0.7) | 0.1 to 0.3 | 0 (0.6) | 0 to 0 | <0.001 |
| Unemployment | 0.1 (0.5) | 0 to 0.2 | 0.1 (0.5) | 0.1 to 0.1 | N/S |
| Pregnancy | 1.4 (0.7) | 1.3 to 1.5 | 1.5 (0.7) | 1.4 to 1.5 | N/S |
| Having <2 years old child | 1.3 (0.8) | 1.2 to 1.4 | 1.4 (0.7) | 1.4 to 1.4 | 0.02 |
| Smoking | −0.1 (0.7) | (−0.2) to 0 | −0.1 (0.7) | (−0.1) to 0 | N/S |
| Drug abuse | −0.5 (0.9) | (−0.6) to (−0.4) | −0.4 (0.9) | (−0.5) to (−0.4) | N/S |
| Having underlying disease | 0.8 (0.9) | 0.7 to 0.9 | 1 (0.9) | 0.9 to 1 | <0.001 |
| Immunocompromise | 0.8 (1) | 0.7 to 0.9 | 1 (0.9) | 0.9 to 1 | <0.001 |
| Malignancy | 0.4 (1.2) | 0.3 to 0.6 | 0.8 (1.1) | 0.8 to 0.9 | <0.001 |
| End-stage status | −0.7 (1.1) | (−0.9) to (−0.6) | −0.4 (1.1) | (−0.4) to (−0.3) | <0.001 |
| Obesity | 0.2 (0.7) | 0.1 to 0.3 | 0.2 (0.6) | 0.2 to 0.2 | N/S |
.